For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.26 in the prior trading day, InMed Pharmaceuticals Inc (NASDAQ: INM) closed at $0.23, down -12.16%. In other words, the price has decreased by -$12.16 from its previous closing price. On the day, 0.55 million shares were traded. INM stock price reached its highest trading level at $0.2599 during the session, while it also had its lowest trading level at $0.2284.
Ratios:
Our goal is to gain a better understanding of INM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.80 and its Current Ratio is at 6.58. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’24 when MANCINI ALEXANDRA DIANE JANET sold 240 shares for $0.18 per share. The transaction valued at 42 led to the insider holds 0 shares of the business.
HULL ANDREW bought 37,500 shares of INM for $14,625 on Feb 21 ’24. The Director now owns 38,258 shares after completing the transaction at $0.39 per share. On Feb 20 ’24, another insider, ADAMS ERIC A, who serves as the President & CEO of the company, bought 41,600 shares for $0.36 each. As a result, the insider paid 14,922 and bolstered with 43,959 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INM now has a Market Capitalization of 2075442 and an Enterprise Value of -4628005. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.14 while its Price-to-Book (P/B) ratio in mrq is 0.13. Its current Enterprise Value per Revenue stands at -0.823 whereas that against EBITDA is 0.72.
Stock Price History:
Over the past 52 weeks, INM has reached a high of $2.08, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -9.54%, while the 200-Day Moving Average is calculated to be -25.01%.
Shares Statistics:
The stock has traded on average 7.03M shares per day over the past 3-months and 1447500 shares per day over the last 10 days, according to various share statistics. A total of 3.33M shares are outstanding, with a floating share count of 3.29M. Insiders hold about 1.06% of the company’s shares, while institutions hold 13.23% stake in the company. Shares short for INM as of 1724976000 were 344528 with a Short Ratio of 0.05, compared to 1722384000 on 253230. Therefore, it implies a Short% of Shares Outstanding of 344528 and a Short% of Float of 3.8599998.
